InMed Pharmaceuticals Inc. entered into a Standby Equity Purchase Agreement allowing it to sell up to $10 million of its common shares to YA II PN, LTD, at its discretion, with specific pricing and conditions outlined. The agreement includes a $25,000 structuring fee and a 2.5% commitment fee on the total amount, with proceeds intended for working capital and corporate purposes.